ANGELYN ENGLAND: Open Payments
NPI 1093757742 · MANHATTAN BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,609 in 90 payments from 19 companies in 2025. Trend: 2023 $1,518 · 2024 $1,722 · 2025 $1,609
Food & beverage: $1,585Education: $24
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $392 |
| ABBVIE INC. | 14 | $268 |
| Biofrontera Inc. | 5 | $116 |
| UCB, Inc. | 4 | $106 |
| MAYNE PHARMA COMMERCIAL LLC | 21 | $88 |
| Incyte Corporation | 3 | $72 |
| Galderma Laboratories, L.P. | 3 | $69 |
| PFIZER INC. | 3 | $60 |
| Journey Medical Corporation | 3 | $59 |
| Arcutis Biotherapeutics, Inc. | 3 | $56 |
Products named: DUPIXENT, BOTOX, Bimzelx, OPZELURA, AKLIEF, CIBINQO, Zoryve, TREMFYA.
Industry payments across CA — which companies pay providers there.
